表紙
市場調查報告書
商品編碼
1035778

組織漿菌病治療的全球市場:產業分析、市場規模、佔有率、成長、趨勢、預測(2020年∼2027年)

Global Histoplasmosis Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2020 to 2027

出版日期: | 出版商: Value Market Research | 英文 166 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球組織漿菌病治療市場,這幾年預計產業顯著成長,在2021年到2027年的預測期間中大幅度成長。

本報告提供全球組織漿菌病治療市場調查,市場概要,產業分析,市場成長要素及阻礙因素,市場機會,產業趨勢,波特的五力分析,價值鏈分析,新型冠狀病毒感染疾病(COVID-19)的爆發的影響分析,各醫藥品、流通管道、地區的詳細趨勢,主要企業簡介等彙整資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 組織漿菌病治療:產業分析

  • 簡介:市場動態
  • 市場成長要素
  • 市場阻礙因素
  • 市場機會
  • 產業趨勢
  • 波特的五力分析
  • 市場魅力分析

第4章 價值鏈分析

  • 價值鏈分析
  • 原料分析
  • 潛在的買主的清單
  • 行銷流通管道

第5章 COVID-19爆發的影響分析

  • COVID-19爆發的影響分析
  • COVID-19生產、進口、出口及各需求影響分析
  • 市場:COVID-19前後比較
  • COVID-19流行的影響預測
  • COVID-19:微觀及宏觀因素分析

第6章 組織漿菌病治療市場分析:各類醫藥品

  • 概要:各類醫藥品
  • 市場資料(成果值、預測值)
  • 市場分析:各類醫藥品
  • Amphotericin B市場:各地區
  • Itraconazole市場:各地區
  • Ketoconazole市場:各地區
  • 其他

第7章 組織漿菌病治療市場分析:各流通管道

  • 概要:各流通管道
  • 市場資料(成果值、預測值)
  • 市場分析:各流通管道
  • 醫院藥局市場:各地區
  • 民間診所市場:各地區
  • 藥妝店、零售藥局市場:各地區
  • 電子商務市場:各地區

第8章 組織漿菌病治療市場分析:各地區

  • 地區預測
  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第9章 組織漿菌病治療市場競爭情形

  • 競爭情形
  • 夥伴關係、合作、契約
  • 合併、收購
  • 新產品的銷售
  • 其他

第10章 企業簡介

  • 企業佔有率分析
  • 市場集中度
  • Bristol Myers Squibb
  • Sigma-Tau Pharmaceuticals Inc.
  • Three Rivers Pharmaceuticals LLC
  • Astellas Pharma US Inc.
  • Abbott Laboratories
  • Abraxis Pharmaceutical Products
  • Teva Parenteral Medicines Inc.
  • X Gen Pharmaceuticals Inc.
目錄
Product Code: VMR11216191

Value Market Research's latest report on the Global Histoplasmosis Treatment Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2021-2027.

The global histoplasmosis treatment market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global histoplasmosis treatment market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global histoplasmosis treatment market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global histoplasmosis treatment market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global histoplasmosis treatment market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global histoplasmosis treatment market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global histoplasmosis treatment market.

The market analysis involves a section exclusively to list the major players of the global histoplasmosis treatment market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Histoplasmosis Treatment Market Report Segments the market as below:

By Drug

  • Amphotericin B
  • Itraconazole
  • Ketoconazole
  • Others

By Distribution Channel

  • Hospitals Pharmacies
  • Private clinics
  • Drug stores and retail pharmacy
  • E-commerce

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . HISTOPLASMOSIS TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Drug
    • 3.7.2 By Distribution Channel
    • 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL HISTOPLASMOSIS TREATMENT MARKET ANALYSIS BY DRUG

  • 6.1 Overview by Drug
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Drug
  • 6.4 Amphotericin B Market by Regions
  • 6.6 Itraconazole Market by Regions
  • 6.5 Ketoconazole Market by Regions
  • 6.7 Others Market by Regions

7 . GLOBAL HISTOPLASMOSIS TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1 Overview by Distribution Channel
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Distribution Channel
  • 7.4 Hospitals Pharmacies Market by Regions
  • 7.5 Private Clinics Market by Regions
  • 7.6 Drug Stores and Retail Pharmacy Market by Regions
  • 7.7 E-commerce Market by Regions

8 . GLOBAL HISTOPLASMOSIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview, Historic and Forecast Data
    • 8.3.2. North America By Segment
    • 8.3.3. North America By Country
    • 8.3.4. United State
    • 8.3.5. Canada
    • 8.3.6. Mexico
  • 8.4. Europe
    • 8.4.1. Overview, Historic and Forecast Data
    • 8.4.2. Europe by Segment
    • 8.4.3. Europe by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7. Italy
    • 8.4.8. Russia
    • 8.4.9. Rest Of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview, Historic and Forecast Data
    • 8.5.2. Asia Pacific by Segment
    • 8.5.3. Asia Pacific by Country
    • 8.5.4. China
    • 8.5.5. India
    • 8.5.6. Japan
    • 8.5.7. South Korea
    • 8.5.8. Australia
    • 8.5.9. Rest Of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview, Historic and Forecast Data
    • 8.6.2. Latin America by Segment
    • 8.6.3. Latin America by Country
    • 8.6.4. Brazil
    • 8.6.5. Argentina
    • 8.6.6. Peru
    • 8.6.7. Chile
    • 8.6.8. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview, Historic and Forecast Data
    • 8.7.2. Middle East & Africa by Segment
    • 8.7.3. Middle East & Africa by Country
    • 8.7.4. Saudi Arabia
    • 8.7.5. UAE
    • 8.7.6. Israel
    • 8.7.7. South Africa
    • 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE HISTOPLASMOSIS TREATMENT COMPANIES

  • 9.1. Histoplasmosis Treatment Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF HISTOPLASMOSIS TREATMENT INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Bristol Myers Squibb
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Sigma-Tau Pharmaceuticals Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Three Rivers Pharmaceuticals LLC
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Astellas Pharma US Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Abbott Laboratories
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Abraxis Pharmaceutical Products
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Teva Parenteral Medicines Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. X Gen Pharmaceuticals Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Drug (USD MN)
  • Amphotericin B Market by Geography (USD MN)
  • Itraconazole Market by Geography (USD MN)
  • Ketoconazole Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by Distribution Channel (USD MN)
  • Hospitals Pharmacies Market by Geography (USD MN)
  • Private Clinics Market by Geography (USD MN)
  • Drug Stores and Retail Pharmacy Market by Geography (USD MN)
  • E-commerce Market by Geography (USD MN)
  • Global Histoplasmosis Treatment Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Histoplasmosis Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Histoplasmosis Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Drug (USD MN)
  • Amphotericin B Market by Geography (USD MN)
  • Itraconazole Market by Geography (USD MN)
  • Ketoconazole Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospitals Pharmacies Market by Geography (USD MN)
  • Private Clinics Market by Geography (USD MN)
  • Drug Stores and Retail Pharmacy Market by Geography (USD MN)
  • E-commerce Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.